US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Provectus Biopharmaceuticals, Inc.

0.0550

-0.0007-1.26%

Volume:42.50K

Turnover:2.22K

Market Cap:23.12M

PE:-4.87

High:0.0557

Open:0.0503

Low:0.0503

Close:0.0557

52wk High:0.0900

52wk Low:0.0380

Shares:420.28M

Float Shares:380.98M

Volume Ratio:0.45

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0113

EPS(LYR):-0.0213

ROE:22.69%

ROA:-236.54%

PB:-3.67

PE(LYR):-2.58

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Provectus Net Loss Narrows 46.6% to $988,716 in Q2 FY26

Provectus Ophthalmology Unit Visirose to Present Rb-pdat at ESCRS Inovation Day 2026 Showcase

Provectus Highlights Study Showing Rose Bengal Sodium Has Opposing Immune Effects at Same Dose

Provectus Biopharmaceuticals Converts $542,500 in Accrued Director Fees into Series D-1 Preferred Shares at $2.86 Each

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/PVCT"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PVCT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVCT\",,,,,undefined,":{"symbol":"PVCT","market":"US","secType":"STK","nameCN":"Provectus Biopharmaceuticals, Inc.","latestPrice":0.055,"timestamp":1789761600000,"preClose":0.0557,"halted":0,"volume":42502,"delay":15,"changeRate":-0.012567324955116683,"floatShares":380975323,"shares":420279879,"eps":-0.0113,"marketStatus":"Market Closed","change":-0.0007,"latestTime":"09-18 16:00:00 EDT Delay","open":0.0503,"high":0.05574,"low":0.0503,"amount":2224.57828,"amplitude":0.097666,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.0113,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.0557,"volumeRatio":0.4486163207924236},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVCT\",,,,,undefined,":{"symbol":"PVCT","floatShares":380975323,"roa":"-236.54%","roe":"22.69%","lyrEps":-0.021324,"volumeRatio":0.4486163207924236,"shares":420279879,"dividePrice":0,"high":0.05574,"amplitude":0.097666,"preClose":0.0557,"low":0.0503,"week52Low":0.038,"pbRate":"-3.67","week52High":0.09,"institutionHeld":0.0005,"latestPrice":0.055,"eps":-0.0113,"divideRate":0,"volume":42502,"delay":15,"ttmEps":-0.0113,"open":0.0503,"prevYearClose":0.0559,"prevWeekClose":0.0566,"prevMonthClose":0.0565,"prevQuarterClose":0.0694,"fiveDayClose":0.0566,"twentyDayClose":0.0551,"sixtyDayClose":0.0684},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PVCT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-12","symbol":"PVCT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-08-13","symbol":"PVCT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-05-14","symbol":"PVCT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-03-28","symbol":"PVCT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1711598400000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-02-22","symbol":"PVCT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1708578000000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PVCT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PVCT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PVCT\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659169156","title":"Provectus Net Loss Narrows 46.6% to $988,716 in Q2 FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2659169156","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659169156?lang=en_us&edition=fundamental","pubTime":"2026-08-14 01:22","pubTimestamp":1786641771,"startTime":"0","endTime":"0","summary":"Provectus net loss narrows 46.6% to $988,716 in Q2 FY26Provectus Biopharmaceuticals posted a net loss of USD 988,716, narrowing 46.6% from a year earlier.Operating loss narrowed 47.9% to USD 938,678 a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL6fHYzl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PVCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653875723","title":"Provectus Ophthalmology Unit Visirose to Present Rb-pdat at ESCRS Inovation Day 2026 Showcase","url":"https://stock-news.laohu8.com/highlight/detail?id=2653875723","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653875723?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:02","pubTimestamp":1784721777,"startTime":"0","endTime":"0","summary":"Provectus ophthalmology unit VisiRose to present RB-PDAT at ESCRS iNovation Day 2026 showcaseVisiRose, Provectus Biopharmaceuticals’ clinical-stage ophthalmology subsidiary, was selected to present RB","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDLbzXc0W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00BN0W2V16.EUR","IE00BKPKM429.USD","LU2210149790.SGD","PVCT","SG9999014005.SGD","IE00BN0W2W23.USD","BK4007","BK4112","LU2210150020.SGD","SG9999014013.SGD","IE00B64PRP62.GBP","LU2095319765.USD","BCDF","LU0314104364.USD","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","BK4588","BK4585","IE00B3QW5Z07.USD","NDAQ","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649878929","title":"Provectus Highlights Study Showing Rose Bengal Sodium Has Opposing Immune Effects at Same Dose","url":"https://stock-news.laohu8.com/highlight/detail?id=2649878929","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649878929?lang=en_us&edition=fundamental","pubTime":"2026-07-07 20:04","pubTimestamp":1783425868,"startTime":"0","endTime":"0","summary":"Provectus highlights study showing rose bengal sodium has opposing immune effects at same doseProvectus highlighted a peer-reviewed University of Lille melanoma study reporting rose bengal sodium show","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDLb2NnlK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PVCT","LU2095319765.USD","SG9999014021.USD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","BK4112","SG9999014013.SGD","BK4585","SG9999014005.SGD","LU0314104364.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","BK4588","SG9999014039.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","BCDF","NDAQ","IE00BGHQF748.EUR","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648151104","title":"Provectus Biopharmaceuticals Converts $542,500 in Accrued Director Fees into Series D-1 Preferred Shares at $2.86 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2648151104","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648151104?lang=en_us&edition=fundamental","pubTime":"2026-07-01 18:04","pubTimestamp":1782900281,"startTime":"0","endTime":"0","summary":"Provectus Biopharmaceuticals converts $542,500 in accrued director fees into Series D-1 preferred shares at $2.86 eachProvectus Biopharmaceuticals will settle accrued directors’ fees through June 30, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDLc5lHDV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PVCT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PVCT\",params:#limit:6,delay:false,,,undefined,":[]}}